Abstract
This report describes the evaluation of N-thiolated β-lactam antibiotics as potential anti- Bacillus agents. N-Thiolated β-lactams are a new family of antibacterials that previously have been found to selectively inhibit the growth of Staphylococcus bacteria over many other genera of microbes. From the data presented herein, these lactams similarly inhibit a variety of Bacillus species, including Bacillus anthracis. The preliminary structure–activity studies suggest that there is a need to balance the lipophilic character of the C 3/C 4 groups in order to obtain optimal anti- Bacillus activity. Elongation or extensive branching of the organothio substitutent diminishes antibacterial effects, with the sec-butylthio derivative providing the strongest activity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
